TP53 and breast cancer: In most subgroups, it was well demonstrated that BC cases with high-risk scores were linked to worse prognosis, especially in the <65 years, Luminal A, Luminal B, T3–4, N1–3, stage III–IV, and TP53 wild-type subgroups (Figure 8F).